ORS 646A.628
Allocation of moneys


Notwithstanding ORS 705.145 (Consumer and Business Services Fund) (2), (3) and (5), the Director of the Department of Consumer and Business Services can allocate as deemed appropriate the moneys derived pursuant to ORS 86A.095 (Short title) to 86A.198 (Materials in languages other than English), 86A.990 (Criminal penalties for violations of ORS 86A.095 to 86A.198), 86A.992 (Civil penalties for violations of ORS 86A.095 to 86A.198), 650.005 (Definitions for ORS 650.005 to 650.100) to 650.100 (Disposition of civil penalties), 697.005 (Definitions for ORS 697.005 to 697.095) to 697.095 (Civil penalties), 697.602 (Definitions for ORS 697.602 to 697.842) to 697.842 (Disposition of moneys received by director), 705.350 (Fees for certain documents) and 717.200 (Definitions) to 717.320 (Short title) and 731.804 (Assessments) and ORS chapters 59, 645, 706 to 716, 723, 725 and 726 to implement ORS 646A.600 (Short title) to 646A.628 (Allocation of moneys). [2007 c.759 §15; 2009 c.541 §23; 2009 c.604 §24]
(Temporary provisions relating to collection of personal health data in connection with COVID-19 exposure)
Note: Sections 1, 4 and 5, chapter 305, Oregon Laws 2021, provide:
Sec. 1. (1) As used in this section:

(a)

Intentionally left blank —Ed.

(A)

“Affirmative express consent” means an affirmative act by a resident individual that clearly and conspicuously communicates the resident individual’s authorization for a covered organization to perform an act or practice.

(B)

“Affirmative express consent” does not include a resident individual’s acceptance of a general or broad terms of use document, or similar document, that contains descriptions of personal health data collection along with other unrelated information.

(b)

Intentionally left blank —Ed.

(A)

“Covered organization” means a person that collects, uses or discloses personal health data or that develops or operates a website, web application, mobile application, mobile operating system feature or other electronic method by means of which the person may collect, use or disclose personal health data.

(B)

“Covered organization” does not include:
(i)
A member of the resident individual’s household;
(ii)
An agency, employee, agent, designee, affiliate, associate or contractor of a federal, state, local or tribal governmental body that under legal authorization and for public health purposes, including preventing disease, injury or disability, may collect, receive, observe, discover or investigate personal health data;
(iii)
A health care provider, as defined in ORS 433.443 (Authority of Public Health Director during public health emergency); or
(iv)
A covered entity or business associate, both as defined in 45 C.F.R. 160.103, as in effect on the effective date of this 2021 Act [June 15, 2021], to the extent that the covered entity or business associate is engaged in activities that are subject to regulation under the Health Insurance Portability and Accountability Act of 1996, P.L. 104-191, or regulations adopted under the Act and codified as 45 C.F.R. parts 160 and 164, as in effect on the effective date of this 2021 Act.

(c)

“Disclose” means to release, transfer, sell, share, provide access to, license or otherwise divulge to another person.

(d)

“Emergency period” means a period that begins on the date on which the Governor has declared an emergency related to the COVID-19 pandemic and ends on a date 180 days after the Governor terminates the declaration or the declaration expires.

(e)

Intentionally left blank —Ed.

(A)

“Geolocation data” means information generated by or derived from technology that directly identifies the location of a natural person within a geographic area that is equal to or less than the area of a circle with a radius of 1,850 feet, including but not limited to:
(i)
Level latitude and longitude coordinates from a global positioning system;
(ii)
Cell site-location information; and
(iii)
Triangulation data derived from nearby wireless or radio frequency networks.

(B)

“Geolocation data” does not include the content of communications.

(f)

Intentionally left blank —Ed.

(A)

“Personal health data” means information that is collected for the purpose of tracking, monitoring or tracing exposures to or infections by SARS-CoV-2 or development of disease conditions caused by or related to COVID-19 and that identifies or can reasonably be used to identify a resident individual and associate the resident individual’s personal identity with:
(i)
Exposure to or infection by SARS-CoV-2 or development of symptoms of or a disease condition caused by or related to COVID-19;
(ii)
Tests or examinations or requests for tests and examinations for exposure to SARS-CoV-2, including tests or examinations of body parts or bodily substances;
(iii)
Receipt of medical care or medical services related to exposure to SARS-CoV-2 or symptoms or development of COVID-19;
(iv)
Predisposition toward developing a disease condition that results from exposure to or infection by SARS-CoV-2;
(v)
Whether the resident individual has received a vaccination against COVID-19; or
(vi)
Other data, including geolocation data, that tracks, monitors or traces a resident individual’s exposure to or infection by SARS-CoV-2 or development of a disease condition caused by or related to COVID-19.

(B)

“Personal health data” does not include information about a resident individual that:
(i)
Is lawfully available to the public from federal, state or local government records or widely available to the public from sources such as telephone directories, the internet, news media or similar or related sources;
(ii)
Was collected before the emergency period for purposes other than tracking, monitoring or tracing a resident individual’s exposure to or infection by SARS-CoV-2 or development of a disease condition caused by or related to COVID-19;
(iii)
Has been deidentified in accordance with 45 C.F.R. 164.514(b), as in effect on the effective date of this 2021 Act;
(iv)
Was collected in an employment context; or
(v)
Is collected after the expiration or termination of the emergency period.

(g)

“Resident individual” means a natural person who resides in this state.

(h)

“Service provider” means a person that collects, uses or discloses personal health data solely for the purpose of providing business services to, on behalf of, or for the benefit of a covered organization in accordance with instructions or direction from, or under the terms and conditions of a contract with, the covered organization.

(2)

Intentionally left blank —Ed.

(a)

Except as provided in paragraph (b) of this subsection, a covered organization may not collect, use or disclose personal health data about a resident individual who has not given affirmative express consent to the covered organization’s collection, use or disclosure of the resident individual’s personal health data. In obtaining affirmative express consent from a resident individual, a covered organization may not:

(A)

Use a method that is designed with the purpose of, or that has the substantial effect of, subverting or impairing a resident individual’s decision-making or choice; and

(B)

Infer consent from a resident individual’s inaction.

(b)

A covered organization may collect, use or disclose personal health data without a resident individual’s affirmative express consent if the collection, use or disclosure is necessary solely to comply with a legal obligation.

(3)

A resident individual may give affirmative express consent to a collection, use or disclosure of personal health data on behalf of another resident individual who is younger than 14 years of age if the resident individual is a parent or legal guardian of the other resident individual.

(4)

Intentionally left blank —Ed.

(a)

Except as provided in paragraph (b) of this subsection, a covered organization may not retain, store or use and shall destroy, delete or, if appropriate, render inaccessible to any person in any manner personal health data that the covered organization collects, stores, uses, possesses or controls not later than 65 days after the covered organization collected, received or otherwise obtained the personal health data.

(b)

A covered organization may use and need not destroy, delete or render inaccessible personal health data if:

(A)

The personal health data consists of aggregations, statistical analyses, compilations or interpretations; and

(B)

The covered organization deidentifies the personal health data in accordance with 45 C.F.R. 164.514(b), as in effect on the effective date of this 2021 Act.

(5)

A covered organization shall collect, use, receive, process, examine, disclose or collate only personal health data that is reasonably necessary to provide services to the resident individual to whom the personal health data applies, and shall:

(a)

Take reasonable measures to ensure the accuracy of the personal health data and provide an accessible and effective method for a resident individual to correct any inaccuracies, as appropriate for the nature of the personal health data and the context in which the covered organization collected or received the personal health data;

(b)

Establish and implement safeguards for personal health data that comply, at a minimum, with the requirements of ORS 646A.622 (Requirement to develop safeguards for personal information) and require service providers by contract to comply with this section and the requirements of ORS 646A.622 (Requirement to develop safeguards for personal information);

(c)

Establish and implement policies and procedures that prevent the covered organization from using personal health data for any discriminatory purpose;

(d)

Provide an easily accessible and effective method by which a resident individual may revoke any affirmative express consent the resident individual gave previously;

(e)

Adopt, implement and provide to each resident individual from whom the covered organization collects, or about whom the covered organization receives, personal health data a clear, understandable and conspicuous disclosure of policies and procedures in compliance with which the covered organization collects, receives or otherwise obtains personal health data that, at a minimum, must include:

(A)

The manner in which and the purposes for which the covered organization collects, receives, processes, examines, analyzes, collates, discloses, transfers, stores, retains or makes use of personal health data;

(B)

Categories of persons to which the covered organization does or may disclose personal health data or from which the covered organization does or may receive or obtain personal health data; and

(C)

A statement that informs the resident individual that and how the resident individual may provide, refuse to provide or revoke affirmative express consent;

(f)

Cease the covered organization’s collection, receipt or use of a resident individual’s personal health data not later than 21 days after receiving from the resident individual a revocation of affirmative express consent; and

(g)

Compile, not later than 30 days after the effective date of this 2021 Act and during each period of 60 days thereafter, and retain for a period of not less than five years after the expiration or termination of the emergency period, subject to an audit by the Oregon Health Authority, a series of reports that:

(A)

States the number of resident individuals from or about whom the covered organization collected, received or otherwise obtained personal health data;

(B)

Describes the categories of personal health data the covered organization collected, received or otherwise obtained and the specific purpose for which the covered organization collected, received or obtained the personal health data; and

(C)

Lists the persons to which the covered organization disclosed, sold or otherwise transferred personal health data.

(6)

A covered organization may not collect, use or disclose personal health data for a purpose that this section does not expressly authorize, including for:

(a)

Commercial advertising;

(b)

Recommendations or reviews related to electronic commerce; or

(c)

Training machine learning algorithms related to or for subsequent use in commercial advertising or electronic commerce.

(7)

This section does not limit or prohibit:

(a)

A university or other institution of higher education or a nonprofit corporation, as defined in ORS 65.001 (Definitions), from conducting scientific research or a public health program or from developing vaccinations, medications or treatments related to COVID-19 that are otherwise authorized by law;

(b)

A covered organization from complying with a federal or state law, a court order, subpoena or other legal process that requires the covered organization or a service provider to disclose personal health data; or

(c)

A covered organization from maintaining, retaining or storing other information in compliance with federal or state law.

(8)

This section does not modify or affect a covered organization’s obligation to comply with the Health Insurance Portability and Accountability Act of 1996, P.L. 104-191, as in effect on the effective date of this 2021 Act, with regulations adopted under the Act or with ORS 192.553 (Policy for protected health information) to 192.581 (Allowed retention or disclosure of genetic information), if applicable.

(9)

A covered organization’s violation of a provision of this section is an unlawful practice under ORS 646.607 (Unlawful business, trade practices). [2021 c.305 §1]
Sec. 4. (1) Section 1 of this 2021 Act and the amendments to ORS 646.607 (Unlawful business, trade practices) by section 2 of this 2021 Act apply to acts to collect, receive, process, examine, analyze, collate, disclose, store or retain personal health data, as defined in section 1 of this 2021 Act, that occur on or after the effective date of this 2021 Act [June 15, 2021].

(2)

A covered organization that collected, used or disclosed personal health data before the effective date of this 2021 Act may not store, retain or make use of personal health data later than, and shall destroy or render the personal health data inaccessible not later than, 65 days after the effective date of this 2021 Act. [2021 c.305 §4]
Sec. 5. Section 1 of this 2021 Act is repealed 270 days after the end of the emergency period, as defined in section 1 of this 2021 Act. [2021 c.305 §5]

Source: Section 646A.628 — Allocation of moneys, https://www.­oregonlegislature.­gov/bills_laws/ors/ors646A.­html.

646A.030
Definitions for ORS 646A.030 to 646A.042
646A.032
Price list for health spa services
646A.034
Contracts
646A.036
Contracts and rules
646A.038
Moneys paid prior to facility opening
646A.040
Waiver of provisions of ORS 646A.030 to 646A.042
646A.042
Remedies and obligations supplementary to existing remedies
646A.050
Definitions
646A.052
Form of purchase agreement
646A.054
Rules
646A.060
Purchase of used goods
646A.062
Penalty for violation of ORS 646A.060
646A.064
Definitions for ORS 646A.064 to 646A.067
646A.065
Records required for transactions involving items of precious metal
646A.066
Applicability to local ordinances
646A.067
Preemption of local requirements applicable to pawnbrokers
646A.068
Penalty for violating ORS 646A.065
646A.070
Sale of telephonic equipment
646A.072
Exceptions to disclosure requirements
646A.075
Required information prior to purchase of dog
646A.077
Qualification for full refund
646A.080
Sale of novelty item containing mercury
646A.081
Prohibition on sale or installation of mercury vapor outdoor lighting fixtures
646A.082
Floral retail sales
646A.085
Sale of rights by distributor to exhibit motion picture without first giving exhibitor opportunity to view motion picture prohibited
646A.090
Offer to sell or lease motor vehicle under retail installment contract or lease agreement
646A.092
Advertisements for sale or lease of motor vehicle
646A.093
Disclosures for handling and shipping consumer goods required in advertisements, offers and sales
646A.095
Disclosure required when purchaser of product offered technical support through information delivery system
646A.097
Payment of sales commissions following termination of contract between sales representative and principal
646A.100
Definitions for ORS 646A.100 to 646A.110
646A.102
Notice of intent to conduct going out of business sale
646A.104
Information required in notice of intent
646A.106
Circumstances in which going out of business sale prohibited
646A.108
Prohibited conduct
646A.110
Applicability of ORS 646A.100 to 646A.110 and 646A.112
646A.112
Injunction of sham sale
646A.115
Software prohibited that interferes with sale of admission tickets to entertainment events
646A.120
Definitions for ORS 646A.120 to 646A.134
646A.122
Applicability of ORS 646A.120 to 646A.134
646A.124
General disclosure requirements
646A.126
Specific disclosure requirements
646A.128
Provisions prohibited in lease-purchase agreements
646A.130
Reinstatement of lease-purchase agreement by consumer
646A.132
Renegotiation or extension of lease-purchase agreement
646A.134
Disclosures required in advertisement for lease-purchase agreements
646A.140
Definitions for ORS 646A.140 and 646A.142
646A.142
Rental vehicle collision damage waiver notice
646A.150
Applicability of ORS 646A.150 to 646A.172
646A.152
Definitions for ORS 646A.150 to 646A.172
646A.154
Service contract defined
646A.156
Required contents of service contracts
646A.158
Prohibited conduct
646A.160
Service contract obligor as agent of insurer
646A.162
Investigation of violations
646A.164
Complaints and investigations confidential
646A.166
Refusal to continue or suspension or revocation of registration
646A.168
Assessment fee
646A.170
Remedies not exclusive
646A.172
Rules
646A.200
Definitions for ORS 646A.202 and 646A.204
646A.202
Payment processing systems
646A.204
Customer information
646A.206
Rules
646A.210
Requiring credit card number as condition for accepting check or share draft prohibited
646A.212
“Credit card” defined
646A.214
Verification of identity in credit or debit card transactions
646A.220
Credit card solicitation
646A.222
Charge card solicitation
646A.230
Action by Attorney General or district attorney
646A.232
Effect of compliance with federal law
646A.240
Treatment of child support obligations by creditor in applications for extensions of credit
646A.242
“Creditor” defined
646A.244
Cause of action for violation of ORS 646A.240
646A.274
Definitions for ORS 646A.276 and 646A.278
646A.276
Sale of gift card that expires, declines in value, includes fee or does not give option to redeem
646A.278
Requirements for sale of gift card that expires
646A.280
Definitions for ORS 646A.280 to 646A.290
646A.282
Simulated invoices prohibited
646A.284
Cause of action by Attorney General
646A.286
Cause of action by private party
646A.288
Presumptions in cause of action brought under ORS 646A.284 or 646A.286
646A.290
Construction
646A.292
Legislative intent
646A.293
Definitions for ORS 646A.293 and 646A.295
646A.295
Prohibited actions
646A.300
Definitions for ORS 646A.300 to 646A.322
646A.302
Application of ORS 646A.300 to 646A.322 to successor in interest or assignee of supplier
646A.304
Payment for farm implements, parts, software, tools and signs upon termination of retailer agreement
646A.306
Repurchase of inventory by supplier
646A.308
Civil action for supplier’s failure to pay
646A.310
Prohibited conduct by supplier
646A.312
Termination, cancellation or nonrenewal of retailer agreement
646A.314
New or relocated dealership
646A.316
Warranty claims
646A.318
Warranty claims
646A.320
Retailer’s improvements to products
646A.322
Remedies
646A.325
Repurchase of motor vehicle by manufacturer
646A.327
Attorney fees for action under ORS 646A.325
646A.340
Definitions for ORS 646A.340 to 646A.348
646A.342
Prohibited conduct
646A.344
Bond or letter of credit
646A.346
Damages
646A.348
Action by Attorney General
646A.350
Delivery of unrequested hazardous substances prohibited
646A.352
Penalty
646A.360
Unsolicited facsimile machine transmissions
646A.362
Exclusion of name from sweepstakes promotion mailing list
646A.365
Check, draft or payment instrument creating obligation for payment
646A.370
Definitions for ORS 646A.370 to 646A.374
646A.372
Limits on usage of automatic dialing and announcing device
646A.374
Prohibited actions
646A.376
Enforcement
646A.400
Definitions for ORS 646A.400 to 646A.418
646A.402
Availability of remedy
646A.404
Consumer’s remedies
646A.405
Manufacturer action under ORS 646A.404
646A.406
Presumption of reasonable attempt to conform
646A.408
Use of informal dispute settlement procedure as condition for remedy
646A.410
Informal dispute settlement procedure
646A.412
Action in court
646A.414
Limitations on actions against dealers
646A.416
Limitation on commencement of action
646A.418
Remedies supplementary to existing statutory or common law remedies
646A.430
Definitions for ORS 646A.430 to 646A.450
646A.432
Applicability of ORS 646A.430 to 646A.450
646A.434
Sale of vehicle protection product
646A.436
Warrantor registration
646A.438
Reimbursement insurance
646A.440
Required provisions of reimbursement insurance policy
646A.442
Vehicle protection product warranty administrator
646A.444
Recordkeeping requirements for warrantor
646A.446
Prohibited conduct for warrantor
646A.448
Prohibited activities
646A.450
Rules
646A.452
Enforcement by Attorney General
646A.460
Definitions for ORS 646A.460 to 646A.476
646A.462
Express warranty
646A.464
Repair of assistive device
646A.466
Replacement or refund after attempt to repair
646A.468
Procedures for replacement or refund
646A.470
Sale or lease of returned assistive device
646A.472
Dispute resolution
646A.474
Applicability of other laws
646A.476
Civil action for damages
646A.480
Definitions for ORS 646A.480 to 646A.495
646A.482
Estimate required before beginning work
646A.486
Prohibited actions if estimate exceeds $200
646A.490
Additional prohibited actions
646A.495
Owner designee
646A.500
Legislative findings
646A.502
Short title
646A.504
Definitions for ORS 646A.500 to 646A.514
646A.506
Prohibited conduct
646A.508
Penalties
646A.510
Exemptions
646A.512
Private right of action
646A.514
Scope of remedies
646A.525
Definitions for ORS 646A.525 to 646A.535
646A.530
Prohibited sales of certain children’s products
646A.535
Assistance of Attorney General in obtaining recall notices
646A.540
Definitions
646A.542
Requirement to document compliance
646A.544
Local government enforcement
646A.550
Short title
646A.555
License to engage in business activity not required for individual under 17 years of age
646A.560
Legislative findings
646A.562
Definitions for ORS 646A.560 to 646A.566
646A.564
Standards for mercury content in electric lamps
646A.566
Considerations for state agency procurement of lighting devices that contain mercury
646A.575
Definitions for ORS 646A.575 to 646A.590
646A.577
Limited license required
646A.580
Cost of coverage
646A.582
Written disclosure requirements
646A.585
Exceptions to license requirement
646A.588
Restrictions on modification or termination of coverage
646A.590
Rules
646A.592
Enforcement
646A.600
Short title
646A.602
Definitions for ORS 646A.600 to 646A.628
646A.604
Notice of breach of security
646A.606
Security freeze
646A.608
Deadline for placing security freeze
646A.610
Fees not permitted
646A.612
Conditions for lifting or removing security freeze
646A.614
Effect of security freeze on use of consumer reports or protective records
646A.616
Effect of request for consumer report subject to security freeze
646A.618
Prohibition on changes to consumer report subject to security freeze
646A.620
Prohibition on printing, displaying or posting Social Security numbers
646A.622
Requirement to develop safeguards for personal information
646A.624
Powers of director
646A.626
Rules
646A.628
Allocation of moneys
646A.640
Definitions
646A.643
License requirement to engage in debt buying
646A.646
License application
646A.649
Licensee’s principal place of business and registered agent
646A.652
Required notices
646A.655
Compliance with director’s standards
646A.658
Prohibited practices
646A.661
Director’s supervisory authority
646A.664
Enforcement actions
646A.667
Preemption
646A.670
Legal action to collect debt
646A.673
Rules
646A.677
Requirement to screen for financial assistance before transferring medical debt for collection
646A.680
Legislative intent
646A.683
Requirement to report increase in drug price
646A.686
Short title
646A.689
Requirement to report certain information concerning drug manufacturing and pricing
646A.692
Civil penalty
646A.693
Prescription Drug Affordability Board
646A.694
Annual affordability determination for identified drugs and insulin products
646A.695
Annual fees assessed against drug manufacturers
646A.696
Report to Health Care Cost Growth Target program and Legislative Assembly
646A.697
Study of market for generic drugs
646A.700
Short title
646A.702
Definitions for ORS 646A.702 to 646A.720
646A.705
Persons that are not foreclosure consultants
646A.710
Foreclosure consulting contract
646A.715
Cancellation
646A.720
Prohibited acts of foreclosure consultant
646A.725
Definitions for ORS 646A.725 to 646A.750
646A.730
Persons that are not equity purchasers
646A.735
Written contract
646A.740
Cancellation
646A.745
Required and prohibited acts
646A.750
Rebuttable presumptions
646A.755
Acts not precluded
646A.760
Civil action for damages
646A.765
Penalties
646A.770
Definitions
646A.773
Applicability of Insurance Code
646A.776
Required disclosures
646A.779
Determination of amount of waiver
646A.781
Cancellation and expiration
646A.784
Reimbursement insurance policies for guaranteed asset protection waivers
646A.787
Fiduciary responsibilities
646A.790
Unlawful practices
646A.800
Late fees on delinquent cable service accounts
646A.801
Termination of residential cable service or residential telecommunications service for certain persons
646A.803
Contest and sweepstakes solicitations
646A.806
Website with photographs and information about arrested persons
646A.808
Obtaining personal information by false representation via electronic media
646A.810
Patent infringement claim made in bad faith
646A.813
Security requirements for Internet-connected devices
Green check means up to date. Up to date